A detailed history of Logos Global Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 575,000 shares of VERA stock, worth $20.8 Million. This represents 2.31% of its overall portfolio holdings.

Number of Shares
575,000
Holding current value
$20.8 Million
% of portfolio
2.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $8.57 Million - $28.3 Million
575,000 New
575,000 $24.8 Million
Q4 2022

Feb 14, 2023

BUY
$15.74 - $22.19 $4.49 Million - $6.32 Million
285,000 New
285,000 $5.51 Million
Q2 2022

Aug 15, 2022

SELL
$12.82 - $23.4 $4.94 Million - $9.01 Million
-385,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$17.8 - $28.06 $5.96 Million - $9.4 Million
335,000 Added 670.0%
385,000 $9.04 Million
Q4 2021

Feb 14, 2022

BUY
$15.01 - $35.8 $750,500 - $1.79 Million
50,000 New
50,000 $1.34 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $978M
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.